Glaxo Seeks Guidance From Health Systems

British pharmaceutical giant GlaxoSmithKline is taking the unusual step of giving government health-care systems a say in deciding which drugs advance in its research pipeline, a move it hopes will result in more products these customers will pay for.
WSJ.com